இராணுவம் வ்யாஂடேஜ் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from இராணுவம் வ்யாஂடேஜ். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In இராணுவம் வ்யாஂடேஜ் Today - Breaking & Trending Today

Palantir Technologies Inc. (PLTR) Q4 2020 Earnings Call Transcript


Rodney Nelson
Good morning. Welcome to Palantir s fourth-quarter 2020 earnings call. We ll be discussing the results announced in our press release issued prior to the market open and posted on our investor relations website. During the call, we will make statements regarding our business that may be considered forward-looking within applicable Securities laws, including statements regarding our first-quarter 2021 and multi-year outlook, management s expectations for our future financial and operational performance, and other statements regarding our plans, prospects, and expectations.
These statements are not promises or guarantees and are subject to risks and uncertainties which could cause them to differ materially from actual results. Information concerning those risks is available in our earnings press release distributed prior to market open today and in our SEC filings. We undertake no obligation to update forward-looking statements, except as required by law. Furth ....

United States , Christopher Merwin Goldman Sachs , Brent Thill Jefferies , Christopher Merwin , Dave Glazer , Keith Weiss , Shyam Sankar , Keith Weiss Morgan Stanley , Rodney Nelson , Kobayashi Maru , Alex Karp , Brad Zelnick , Brent Thill , Morgan Stanley , Rio Tinto , Oncology Center , Drug Administration , Goldman Sachs , Credit Suisse , Us Army , Army Vantage , Alex Karp Co , Palantir Technologies Inc , Chief Executive , Kevin Kawasaki , Innovation Awards ,

3 New Catalysts for Palantir's High-Flying Stock


Palantir s (NYSE:PLTR) stock has roughly tripled in price since its direct listing three months ago. Interest in the data-mining firm s stock was initially tepid due to its controversial business model, heavy dependence on government contracts, lack of profits, and ongoing insider sales.
However, Palantir s third-quarter earnings report in November which featured accelerating revenue growth, expanding gross margins, new government contracts, and enterprise renewals attracted a stampede of bulls.
Palantir s stock now trades at nearly 40 times next year s sales, and some analysts are warning that the stock could be too hot to handle. That caution is warranted, but three recent developments have kept the bulls engaged over the past month. ....

United Kingdom , Uk National Health Service , Oncology Center , Us Army , Drug Administration , Army Vantage , Drug Evaluation , Public Sector Government Innovation Award , Health Service , ஒன்றுபட்டது கிஂக்டம் , இங்கிலாந்து தேசிய ஆரோக்கியம் சேவை , புற்றுநோயியல் மையம் , எங்களுக்கு இராணுவம் , இராணுவம் வ்யாஂடேஜ் , மருந்து மதிப்பீடு , பொது துறை அரசு கண்டுபிடிப்பு விருது , ஆரோக்கியம் சேவை ,